A bioinformatic analysis of APOBEC3 expression in DLBCL revealed that APOBEC3B but not APOBEC3A was upregulated in DLBCL in several lymphoma databases, suggesting that it is responsible for TP53 mutations in DLBCL. This evidence concerns the gene APOBEC3B and diffuse large B-cell lymphoma.